These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6150753)

  • 1. Canine malignant hyperthermia susceptibility: erythrocytic defects--osmotic fragility, glucose-6-phosphate dehydrogenase deficiency and abnormal Ca2+ homeostasis.
    O'Brien PJ; Forsyth GW; Olexson DW; Thatte HS; Addis PB
    Can J Comp Med; 1984 Oct; 48(4):381-9. PubMed ID: 6150753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine stress syndrome/malignant hyperthermia susceptibility: calcium-homeostasis defect in muscle and lymphocytes.
    O'Brien PJ; Pook HA; Klip A; Britt BA; Kalow BI; McLaughlin RN; Scott E; Elliott ME
    Res Vet Sci; 1990 Jan; 48(1):124-8. PubMed ID: 2300706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porcine malignant hyperthermia susceptibility: erythrocytic osmotic fragility.
    O'Brien PJ; Rooney MT; Reik TR; Thatte HS; Rempel WE; Addis PB; Louis CF
    Am J Vet Res; 1985 Jul; 46(7):1451-6. PubMed ID: 4026025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte osmotic fragility, serum creatine kinase and its isoenzymes related to body weight in porcine malignant hyperthermia.
    Doizé F; Roux I; DeRoth L
    J Comp Pathol; 1990 May; 102(4):467-73. PubMed ID: 2365858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte fragility screening is not a tool for diagnosis of human malignant hyperthermia.
    Kistler P; Fletcher JE; Rosenberg H
    Anesth Analg; 1987 Oct; 66(10):1004-7. PubMed ID: 3631560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant hyperthermia: characterization of erythrocyte membranes from individuals at risk.
    Godin DV; Herring FG; MacLeod PJ
    J Med; 1981; 12(1):35-49. PubMed ID: 6455481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte membrane ATPase activity of G6PD-deficient individuals and the effect of primaquine metabolite(s) on membrane ATPase enzymes.
    Akoğlu T; Ozdoğu H; Erdoğan R; Ozer FL
    J Trop Med Hyg; 1984 Oct; 87(5):219-24. PubMed ID: 6152296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte membrane ATPase and calcium pumping activities in porcine malignant hyperthermia.
    Thatte HS; Mickelson JR; Addis PB; Louis CF
    Biochem Med Metab Biol; 1987 Dec; 38(3):355-65. PubMed ID: 2963654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte osmotic fragility and cation concentrations during experimentally induced bovine anaplasmosis.
    Silva IM; Hubsch C; Ysern-Caldentey M
    Comp Biochem Physiol A Comp Physiol; 1989; 94(3):455-9. PubMed ID: 2574096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of pH, temperature, halothane and its metabolites on osmotic fragility of erythrocytes of malignant hyperthermia-susceptible and resistant pigs.
    Heffron JJ; Mitchell G
    Br J Anaesth; 1981 May; 53(5):499-504. PubMed ID: 7236474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial calcium, erythrocyte fragility and porcine malignant hyperthermia.
    Cheah KS; Cheah AM
    FEBS Lett; 1979 Nov; 107(2):265-8. PubMed ID: 510535
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of anaesthetic agents on erythrocyte fragility: comparison of normal and malignant hyperthermia susceptible patients.
    Tolpin EI; Fletcher JE; Rosenberg H; Michaux K
    Can J Anaesth; 1987 Jul; 34(4):366-72. PubMed ID: 3608052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte osmotic fragility in porcine malignant hyperthermia and effects of halothane.
    Reiner G; Dzapo V
    Zentralbl Veterinarmed A; 1989 Apr; 36(4):269-75. PubMed ID: 2506706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant hyperthermia susceptibility: cardiac histomorphometry of dogs and young and market-weight swine.
    O'Brien PJ; Fletcher TF; Metz AL; Kurtz HJ; Reed BK; Rempel WE; Clark EG; Louis CF
    Can J Vet Res; 1987 Jan; 51(1):50-5. PubMed ID: 3567752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant hyperthermia in dogs.
    Nelson TE
    J Am Vet Med Assoc; 1991 Mar; 198(6):989-94. PubMed ID: 2032926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise-induced malignant hyperthermia in an English springer spaniel.
    Rand JS; O'Brien PJ
    J Am Vet Med Assoc; 1987 Apr; 190(8):1013-4. PubMed ID: 3570952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A water-extractable Ca2+-atpase from erythrocyte membranes.
    White MD; Ralston GB
    Biochim Biophys Acta; 1980 Mar; 596(3):372-5. PubMed ID: 6102478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte osmotic fragility in protein-energy malnutrition: cholesterol, phospholipid, and CA2+, Mg2+ adenosine triphosphatase.
    Ramanadham M; Kaplay SS
    Biochem Med; 1982 Apr; 27(2):226-31. PubMed ID: 6123320
    [No Abstract]   [Full Text] [Related]  

  • 19. Red blood cell calmodulin and Ca2+ pump ATPase: preliminary results of a species comparison.
    Vincenzi FF
    Prog Clin Biol Res; 1981; 55():363-83. PubMed ID: 6117080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haematological parameters and altered erythrocyte metabolism in anaemic dogs.
    Paltrinieri S; Comazzi S; Agnes F
    J Comp Pathol; 2000 Jan; 122(1):25-34. PubMed ID: 10627388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.